738 related articles for article (PubMed ID: 12073159)
21. Interaction between naltrexone and oral THC in heavy marijuana smokers.
Haney M; Bisaga A; Foltin RW
Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
[TBL] [Abstract][Full Text] [Related]
22. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress.
Childs E; Lutz JA; de Wit H
Drug Alcohol Depend; 2017 Aug; 177():136-144. PubMed ID: 28599212
[TBL] [Abstract][Full Text] [Related]
23. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
[TBL] [Abstract][Full Text] [Related]
24. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
[TBL] [Abstract][Full Text] [Related]
25. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
26. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
Sugarman DE; Poling J; Sofuoglu M
Pharmacol Biochem Behav; 2011 Mar; 98(1):94-100. PubMed ID: 21176784
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.
Kauert GF; Ramaekers JG; Schneider E; Moeller MR; Toennes SW
J Anal Toxicol; 2007 Jun; 31(5):288-93. PubMed ID: 17579974
[TBL] [Abstract][Full Text] [Related]
28. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
[TBL] [Abstract][Full Text] [Related]
29. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
[TBL] [Abstract][Full Text] [Related]
30. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
Hart CL; Haney M; Vosburg SK; Comer SD; Foltin RW
Psychopharmacology (Berl); 2005 Sep; 181(2):237-43. PubMed ID: 15830233
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of alcohol and marijuana on mood, memory, and performance.
Heishman SJ; Arasteh K; Stitzer ML
Pharmacol Biochem Behav; 1997 Sep; 58(1):93-101. PubMed ID: 9264076
[TBL] [Abstract][Full Text] [Related]
32. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
[TBL] [Abstract][Full Text] [Related]
33. Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.
Böcker KB; Gerritsen J; Hunault CC; Kruidenier M; Mensinga TT; Kenemans JL
Pharmacol Biochem Behav; 2010 Jul; 96(1):67-74. PubMed ID: 20417659
[TBL] [Abstract][Full Text] [Related]
34. Ethanol increases plasma Delta(9)-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers.
Lukas SE; Orozco S
Drug Alcohol Depend; 2001 Oct; 64(2):143-9. PubMed ID: 11543984
[TBL] [Abstract][Full Text] [Related]
35. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.
Haney M; Gunderson EW; Rabkin J; Hart CL; Vosburg SK; Comer SD; Foltin RW
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):545-54. PubMed ID: 17589370
[TBL] [Abstract][Full Text] [Related]
36. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
Cooper ZD; Comer SD; Haney M
Neuropsychopharmacology; 2013 Sep; 38(10):1984-92. PubMed ID: 23609132
[TBL] [Abstract][Full Text] [Related]
38. Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.
Wachtel SR; de Wit H
Drug Alcohol Depend; 2000 Jun; 59(3):251-60. PubMed ID: 10812285
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
Greenwald MK; Stitzer ML
Drug Alcohol Depend; 2000 Jun; 59(3):261-75. PubMed ID: 10812286
[TBL] [Abstract][Full Text] [Related]
40. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
